A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors
NCT00329004
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Tumor
Interventions
DRUG:
BMS-690514
Sponsor
Bristol-Myers Squibb